<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?properties manuscript?><front><journal-meta><journal-id journal-id-type="nlm-journal-id">101624393</journal-id><journal-id journal-id-type="pubmed-jr-id">42200</journal-id><journal-id journal-id-type="nlm-ta">Health Psychol Behav Med</journal-id><journal-id journal-id-type="iso-abbrev">Health Psychol Behav Med</journal-id><journal-title-group><journal-title>Health psychology and behavioral medicine</journal-title></journal-title-group><issn pub-type="epub">2164-2850</issn></journal-meta><article-meta><article-id pub-id-type="pmid">28966882</article-id><article-id pub-id-type="pmc">5617138</article-id><article-id pub-id-type="doi">10.1080/21642850.2016.1271333</article-id><article-id pub-id-type="manuscript">NIHMS854456</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Evaluation of the effect of cellular SMS reminders on consistency of antiretroviral therapy pharmacy pickups in HIV-infected adults in Botswana: a randomized controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Reid</surname><given-names>Michael J. A.</given-names></name><xref ref-type="aff" rid="A1">a</xref><xref rid="FN1" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name><surname>Steenhoff</surname><given-names>Andrew P.</given-names></name><xref ref-type="aff" rid="A2">b</xref><xref ref-type="aff" rid="A3">c</xref><xref ref-type="aff" rid="A4">d</xref><xref ref-type="aff" rid="A5">e</xref><xref rid="FN2" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name><surname>Thompson</surname><given-names>James</given-names></name><xref ref-type="aff" rid="A6">f</xref></contrib><contrib contrib-type="author"><name><surname>Gabaitiri</surname><given-names>Lesego</given-names></name><xref ref-type="aff" rid="A7">g</xref></contrib><contrib contrib-type="author"><name><surname>Cary</surname><given-names>Mark S.</given-names></name><xref ref-type="aff" rid="A8">h</xref></contrib><contrib contrib-type="author"><name><surname>Steele</surname><given-names>Katherine</given-names></name><xref ref-type="aff" rid="A3">c</xref></contrib><contrib contrib-type="author"><name><surname>Mayisela</surname><given-names>Susan</given-names></name><xref ref-type="aff" rid="A2">b</xref></contrib><contrib contrib-type="author"><name><surname>Dickinson</surname><given-names>Diana</given-names></name><xref ref-type="aff" rid="A9">i</xref></contrib><contrib contrib-type="author"><name><surname>Ehrenkranz</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="A10">j</xref></contrib><contrib contrib-type="author"><name><surname>Friedman</surname><given-names>Harvey M.</given-names></name><xref ref-type="aff" rid="A2">b</xref><xref ref-type="aff" rid="A3">c</xref><xref ref-type="aff" rid="A4">d</xref><xref ref-type="aff" rid="A11">k</xref></contrib><contrib contrib-type="author"><name><surname>Linkin</surname><given-names>Darren R.</given-names></name><xref ref-type="aff" rid="A4">d</xref><xref ref-type="aff" rid="A11">k</xref></contrib></contrib-group><aff id="A1">
<label>a</label>Division of Infectious Diseases, UCSF, San Francisco, CA, USA</aff><aff id="A2">
<label>b</label>Botswana-UPenn Partnership, Gaborone, Botswana</aff><aff id="A3">
<label>c</label>Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA</aff><aff id="A4">
<label>d</label>Center for AIDS Research, University of Pennsylvania, Philadelphia, PA, USA</aff><aff id="A5">
<label>e</label>Department of Pediatrics, Division of Infectious Diseases, The Children&#x02019;s Hospital of Philadelphia, Philadelphia, PA, USA</aff><aff id="A6">
<label>f</label>The Wharton School, University of Pennsylvania, Philadelphia, PA, USA</aff><aff id="A7">
<label>g</label>Department of Medicine, School of Medicine, University of Botswana, Gaborone, Botswana</aff><aff id="A8">
<label>h</label>Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA</aff><aff id="A9">
<label>i</label>Independence Surgery, Gaborone, Botswana</aff><aff id="A10">
<label>j</label>Bill &#x00026; Melinda Gates Foundation, Seattle, WA, USA</aff><aff id="A11">
<label>k</label>Department of Medicine, Division of Infectious Diseases, University of Pennsylvania, Philadelphia, PA, USA</aff><author-notes><corresp id="FN1"><bold>CONTACT</bold> Michael J. A. Reid <email>michael.reid2@ucsf.edu</email></corresp><fn id="FN2"><label>*</label><p>Shared first authorship.</p></fn></author-notes><pub-date pub-type="nihms-submitted"><day>16</day><month>3</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>9</day><month>1</month><year>2017</year></pub-date><pub-date pub-type="ppub"><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>27</day><month>9</month><year>2017</year></pub-date><volume>5</volume><issue>1</issue><fpage>101</fpage><lpage>109</lpage><!--elocation-id from pubmed: 10.1080/21642850.2016.1271333--><permissions><license license-type="open-access"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://www.tandfonline.com/doi/full/10.1080/21642850.2016.1271333"/><abstract><sec id="S1"><title>Objective</title><p id="P1">Several studies have demonstrated that cellular phone short message service (SMS) improve antiretroviral adherence for people living with HIV in Africa, although less data are available to support using SMS reminders to improve timeliness of antiretroviral therapy (ART) pharmacy pick up. This study tested the efficacy of SMS reminders on timeliness of ART pharmacy pickups at an urban clinic in Gaborone, Botswana.</p></sec><sec id="S2"><title>Design</title><p id="P2">A randomized-controlled trial evaluating the effect of SMS reminders on ART collection for patients with HIV on treatment.</p></sec><sec id="S3"><title>Methods</title><p id="P3">One hundred and eight treatment-experienced adult patients were enrolled and randomly assigned to a control group or an intervention group. Participants in the intervention group received SMS reminders that were sent in advance of monthly ART refills that needed to be collected. The primary outcome was 100% timeliness of pharmacy ART pickups. Secondary outcomes included frequency of physician visits, CD4 cell counts and viral loads.</p></sec><sec id="S4"><title>Results</title><p id="P4">Baseline characteristics in the intervention (<italic>n</italic> = 54) and control arms (<italic>n</italic> = 54) were similar. After six months, 85% of those receiving SMS reminders were 100% on time picking up monthly ART refills compared to 70% in the control group (<italic>p</italic> = 0.064). In secondary analysis, there were no significant changes in the CD4 counts and viral loads over the course of the study.</p></sec><sec id="S5"><title>Conclusions</title><p id="P5">Timeliness of ART pickup was not significantly improved by SMS reminders. Additionally, the intervention had no impact on immunologic or virologic outcomes in treatment-experienced patients.</p></sec></abstract><kwd-group><kwd>HIV</kwd><kwd>adherence</kwd><kwd>SMS</kwd><kwd>Botswana</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="S6"><title>Introduction</title><p id="P6">Antiretroviral therapy (ART) has significantly reduced morbidity and mortality for people living with HIV/AIDS in Sub-Saharan Africa (SSA) (<xref rid="R16" ref-type="bibr">Palella et al., 1998</xref>). While initial concerns about poor adherence and widespread drug resistance have not been realized, evidence suggests that medication adherence among individuals in Sub-Saharan Africa does decline over time (<xref rid="R2" ref-type="bibr">Byakika-Tusiime et al., 2009</xref>; <xref rid="R9" ref-type="bibr">Mannheimer et al., 2005</xref>). Given the prohibitive costs of second and third line therapy, successful adherence support and retention interventions may be cost saving (<xref rid="R22" ref-type="bibr">Unge et al., 2009</xref>).</p><p id="P7">Mobile phone text messages using the short message service (SMS) have been demonstrated to be a feasible and affordable means of improving ART adherence (<xref rid="R3" ref-type="bibr">Finitsis, Pellowski, &#x00026; Johnson, 2014</xref>; <xref rid="R6" ref-type="bibr">Kelly &#x00026; Giordano, 2011</xref>; <xref rid="R13" ref-type="bibr">Mills et al., 2014</xref>; <xref rid="R17" ref-type="bibr">Pop-Eleches et al., 2011</xref>; <xref rid="R18" ref-type="bibr">Riaz, Riaz, Hussain, &#x00026; Kherani, 2012</xref>; <xref rid="R23" ref-type="bibr">Vodopivec-Jamsek, de Jongh, Gurol-Urganci, Atun, &#x00026; Car, 2012</xref>). Furthermore, mobile phones are widely available across Africa (<xref rid="R1" ref-type="bibr">Bank, 2012</xref>). We undertook a randomized-controlled trial at a single site in Gabor-one, Botswana, to assess whether SMS reminders improved timeliness of pharmacy pickup of antiretroviral medications for HIV-infected adults.</p></sec><sec sec-type="methods" id="S7"><title>Methods</title><p id="P8">From April 2008 to July 2009, we completed a randomized-controlled trial testing the efficacy of SMS texts to improve timeliness of pharmacy pickup visits among a sample of HIV-infected adults. The study was conducted at Independence Surgery, an urban private clinic in Gaborone, Botswana&#x02019;s capital city. At the time of the study, all participants resided within cell phone network coverage.</p><p id="P9">Potentially eligible subjects were HIV-infected adults &#x02265;21 years old on ART and receiving HIV care at the study clinic. Patients were ineligible if they did not intend to have continuous follow-up care and monthly medication refills at Independence Surgery for at least three months after enrollment (e.g. due to travel or studying abroad). Eligible patients were informed about the study and then asked to consent in either English or Setswana. Those individuals who did not already own a phone were provided with one for the duration of the study. The protocol was approved by the Institutional Review Boards of the Botswana Ministry of Health and the University of Pennsylvania and registered at <ext-link ext-link-type="uri" xlink:href="http://www.clinicaltrials.gov">www.clinicaltrials.gov</ext-link>, NCT01001741 prior to study commencement.</p></sec><sec id="S8"><title>Design</title><p id="P10">Participants were screened, consented, and enrolled by the study research staff on site. They were then randomly assigned in a 1:1 ratio to the intervention group (SMS reminder messages) or the control group (usual care). Randomization, laboratory assays, and analyses were done by investigators masked to treatment allocation. Study participants and clinic staff could not be masked because the intervention required overt participation.</p></sec><sec id="S9"><title>Intervention</title><p id="P11">The intervention, including phrasing of the SMS reminders, was developed after extensive consultation with clinic staff and expert patients. Those participants randomized to the intervention arm received SMS reminders three days prior, one day prior, and the morning of the scheduled monthly pharmacy pickup. All messages were fewer than 160 characters and did not specify HIV or ART in order to maintain confidentiality of HIV status. Messages were automatically sent out using the Independence Clinical Decision Support System (Wharton Entrepreneurial Programs, Philadelphia, 2006). The service sent &#x02018;one-way&#x02019; messages to which recipients could not respond.</p></sec><sec id="S10"><title>Data collection and measures</title><p id="P12">Participants collected antiretroviral refills monthly, as per the clinic&#x02019;s standard approach at that time. The primary outcome, timeliness of ART pharmacy pickups, was calculated from the number of attended pharmacy visits from 14 days after enrollment through 187 days after enrollment. A total of six or more visits during the six-month period was considered 100% adherence to pharmacy pickups. Fewer visits were divided by six to obtain a percentage of adherence. Thus, three visits equated to 50% adherence. The 100% level was chosen as the primary outcome because HIV regimens require greater than 95% adherence for maximal effectiveness and less than 100% ART pick up during the study period would have led to significantly less than 95% ART adherence. Secondary outcomes included suppression of plasma HIV-1 viral load (VL), defined as 400 copies per ml or less, CD4 counts, and the number of physician visits during the study period. Pharmacy records were recorded monthly by study staff in the clinic&#x02019;s dispensary. Clinic visits for other reasons &#x02013; such as to visit with a clinician &#x02013; were not documented as evidence of ART pick up.</p></sec><sec id="S11"><title>Data analysis</title><p id="P13">Analyses were performed using an intention-to-treat approach. Baseline and outcome differences between the two groups were tested in bivariate analyses with parametric and nonparametric statistics, as appropriate. Logistic regression was used to determine if there was association between baseline characteristics and 100% adherence. We regressed the adherence on intervention, order of recruitment, and one baseline covariate at a time to find covariates with a significance of <italic>p</italic> &#x0003c; 0.10. Order of recruitment was included in regression analysis in order to mitigate for unanticipated recruitment bias. All analyses were conducted with SAS Version 9.3 (SAS Institute, Cary, N.C., USA). With a sample of 108, the study had &#x0003e;80% power to detect an improvement in baseline adherence of 67% to 90% of pharmacy pickup of antiretrovirals between the treatment and control arms.</p></sec><sec sec-type="results" id="S12"><title>Results</title><sec id="S13"><title>Sample characteristics</title><p id="P14">One hundred and eight participants were enrolled and randomized (<italic>n</italic> = 54 intervention, <italic>n</italic> = 54 control) and were included in all subsequent analyses. An additional 20 participants participated, in whom random allocation did not occur, were excluded from the study. Among the 108 participants, mean age was 40.8 years in the intervention arm, and 41.4 years in the control arm. More than 70% in both arms had been on ART for at least 4 years at the time of enrollment. There were no significant differences in demographic characteristics between intervention and control participants, including age, education, residence, and gender (<xref rid="T1" ref-type="table">Table 1</xref>). Cell phone ownership did not vary by treatment arm; 96% of all participants owned a phone at the time of enrollment. Groups were also balanced by distance from the clinic and type of ART regimen (<xref rid="T2" ref-type="table">Table 2</xref>).</p></sec></sec><sec id="S14"><title>Intervention efficacy</title><p id="P15">In the post-intervention assessment, 85% of participants receiving SMS reminders demonstrated 100% six-month timely pharmacy pickups compared to 70% timely ART pickup in the control group (<italic>p</italic> = 0.064). Using logistic regression to predict 100% timeliness to pharmacy pickups, the odds ratio (95% confidence interval) for SMS reminders was 2.42 (0.94, 6.27). Including both the intervention and order of recruitment in the regression analysis produced an odds ratio of 2.40 (0.90, 6.42) for SMS reminders and 9.96 (1.72, 57.67) for the order of recruitment, where the first patient recruited was assigned a 1, the last a 0, and all those in-between an evenly spaced fractional value. In secondary analysis, there were no significant differences in the changes of CD4 count between the intervention and control groups. While mean log HIV VL was lower in the intervention group at the end of six months (5.31 vs. 3.88, <italic>p</italic> = 0.05), the difference in VL from baseline across the groups was not statistically significant (&#x02212;0.24 vs. 0.09, <italic>p</italic> = 0.14). There was also no difference in frequency of clinic visits or loss to follow-up rates between the two groups. No adverse events occurred during the study period.</p></sec><sec sec-type="discussion" id="S15"><title>Discussion</title><p id="P16">In this study, receiving SMS reminders did not lead to a significant improvement in timeliness of ART refill pick up. In addition, after six months of follow up, we found no evidence that the intervention had had a beneficial impact on clinical, immunologic, or virologic outcomes.</p><p id="P17">It is important to examine plausible factors that contributed to the intervention not producing the intended effects. First, it is possible that the short time frame of the RCT &#x02013; six months of follow up &#x02013; was inadequate to characterize a measurable effect. Secondly, we acknowledge that the intervention&#x02019;s effect may have been mitigated by the type of patients enrolled; the majority (70%) had been on ART for at least 48 months at enrollment into the study. Furthermore, at baseline, most patients in both intervention and control arm had very low or undetectable viral loads (under 400 copies/ml), suggesting that many were already reasonably adherent with their medications. Such patients may be more accustomed to the routine of picking up medications each month. We speculate that the SMS reminder may be more effective in treatment-na&#x000ef;ve populations, who are less likely to have established cues to help remind them to pickup medications each month and have the greatest challenges in establishing adherence habits (<xref rid="R24" ref-type="bibr">Wilson et al., 2013</xref>).</p><p id="P18">Notably, our negative results do not support the findings of other published trials in Kenya (<xref rid="R7" ref-type="bibr">Lester et al., 2010</xref>; <xref rid="R17" ref-type="bibr">Pop-Eleches et al., 2011</xref>) and Cameroon (<xref rid="R12" ref-type="bibr">Mbuagbaw et al., 2012</xref>) that have reported positive impacts of SMS reminders on medication adherence (<xref rid="R11" ref-type="bibr">Mbuagbaw et al., 2013</xref>). While interventions and outcomes in these studies were different, they demonstrated that text messaging can have significant effects on adherence to ART, although this effect was influenced by level of education, gender, timing (weekly vs. daily) and SMS interactivity.</p><p id="P19">To our knowledge, our study is the first to explore the role of SMS as a tool to improve pharmacy pickup in an African setting. One possible explanation for lack of significant finding in our analysis was that reminding people to pick up the pills is far less likely to impact pill adherence than interventions focused on improving real-time ART adherence. A number of recent studies (<xref rid="R4" ref-type="bibr">Haberer et al., 2016</xref>; <xref rid="R14" ref-type="bibr">Orrell et al., 2015</xref>; <xref rid="R19" ref-type="bibr">Sabin et al., 2015</xref>) have demonstrated the benefit of using SMS reminders in tandem with real-time electronic adherence monitoring devices that record when medications containers are opened and communicate the data to a central server, such as the Wisepill (&#x0201c;<xref rid="R25" ref-type="bibr">Wisepill Technologies,&#x0201d; 2016</xref>). However, recent evidence suggests that real-time electronic adherence monitoring and support is particularly beneficial for those initiating ART, compared to those with prior ART experience (<xref rid="R5" ref-type="bibr">Haberer et al., 2017</xref>). While our analysis failed to demonstrate a significant effect, our results build upon and confirms previous work indicating that effective SMS ART adherence interventions should be individualized to those most likely to benefit from them (<xref rid="R20" ref-type="bibr">Sabin et al., 2010</xref>; <xref rid="R21" ref-type="bibr">Simoni, Amico, Smith, &#x00026; Nelson, 2010</xref>). Wireless monitoring and text reminder interventions are relatively simple and can be used as a tool by providers and adherence counselors already in the field. The potential for broad scalability may make it feasible to target specifically patients known to be poorly adherent or those who develop resistance (<xref rid="R20" ref-type="bibr">Sabin et al., 2010</xref>).</p><p id="P20">This RCT has several potential limitations. We acknowledge that our sample size was small and so we were limited in ability to detect a smaller difference in outcomes between the control and intervention groups. Furthermore, we excluded 20 study participants that were not randomly allocated to the intervention or control groups. Notably, ethnic or socioeconomic data on study participants was not documented. Furthermore, we acknowledge that the measure of retention to care used in this study (pharmacy pickups) may have over-estimated antiretroviral adherence rate. Nevertheless, timely pharmacy pickup is a commonly accepted metric of medication adherence (<xref rid="R8" ref-type="bibr">Liu et al., 2001</xref>; <xref rid="R10" ref-type="bibr">Martin et al., 2009</xref>) that correlated strongly with virologic suppression in our analysis and serves as a sensitive marker of loss to follow up in real-world practice (<xref rid="R15" ref-type="bibr">Orrell, Leisegang, Bangsberg, Maartens, &#x00026; Wood, 2016</xref>). Finally, we acknowledge that the time from study completion to publication may limit the relevance of the findings, not least because of rapid scale up in use of SMS interventions to support HIV programs across SSA in the interim. However, we believe that our results remain relevant insofar as they illustrate the marginal benefit of SMS reminders to improve ART adherence in treatment-experienced patients who are doing well on therapy.</p></sec><sec id="S16"><title>Summary</title><p id="P21">SMS reminders did not significantly improve timeliness of ART pharmacy pickups among treatment-experienced patients accessing care at an urban private clinic in urban Botswana. Additionally, reminders had no impact on immunologic or virologic outcomes. SMS reminders might have a greater impact in other settings or with a less experienced patient population.</p></sec></body><back><ack id="S17"><p>A.P.S. and D.R.L. were involved in the study conception, design, implementation, data acquisition and analysis, drafting, and final approval of version to be published. J.T. was involved in the study conception, design, implementation, data acquisition, drafting, and final approval of version to be published. L.G. was involved in the study design, implementation, data acquisition and analysis, drafting, and final approval of version to be published. M.J.A.R. and M.S.C. were involved in the study data analysis, drafting, and final approval of version to be published. K.T.S. was involved in the study implementation, data acquisition and analysis, drafting, and final approval of version to be published. S.M. was involved in data acquisition, article revision, and final approval of the version to be published. D.D. was involved in the study conception, design, implementation, data acquisition, drafting, and final approval of version to be published. P.E. was involved in aiding the study design, article revision and final approval of version to be published. H.F. was involved in the study conception, design, implementation, data analysis, drafting, and final approval of version to be published. We acknowledge the staff and patients of Independence Surgery, Gaborone for kindly supporting this study. The trial is registered at <ext-link ext-link-type="uri" xlink:href="http://ClinicalTrials.gov">ClinicalTrials.gov</ext-link>, NCT01001741.</p><p><bold>Funding</bold></p><p>This research was supported by a grant from the Penn Center for AIDS Research (CFAR), an NIH-funded program (grant number P30 AI 045008).</p></ack><fn-group><fn fn-type="COI-statement" id="FN3"><p>Disclosure statement</p><p>No potential conflict of interest was reported by the authors.</p></fn></fn-group><ref-list><ref id="R1"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bank</surname><given-names>W</given-names></name></person-group><year>2012</year><source>Information and communication technologies</source><comment>2014</comment><month>3</month><day>6</day><publisher-name>World Bank</publisher-name></element-citation></ref><ref id="R2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byakika-Tusiime</surname><given-names>J</given-names></name><name><surname>Crane</surname><given-names>J</given-names></name><name><surname>Oyugi</surname><given-names>JH</given-names></name><name><surname>Ragland</surname><given-names>K</given-names></name><name><surname>Kawuma</surname><given-names>A</given-names></name><name><surname>Musoke</surname><given-names>P</given-names></name><name><surname>Bangsberg</surname><given-names>DR</given-names></name></person-group><year>2009</year><article-title>Longitudinal antiretroviral adherence in HIV+ Ugandan parents and their children initiating HAART in the MTCT-Plus family treatment model: Role of depression in declining adherence over time</article-title><source>AIDS and Behavior</source><volume>13</volume><issue>Suppl. 1</issue><fpage>82</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1007/s10461-009-9546-x</pub-id><pub-id pub-id-type="pmid">19301113</pub-id></element-citation></ref><ref id="R3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finitsis</surname><given-names>DJ</given-names></name><name><surname>Pellowski</surname><given-names>JA</given-names></name><name><surname>Johnson</surname><given-names>BT</given-names></name></person-group><year>2014</year><article-title>Text message intervention designs to promote adherence to antiretroviral therapy (ART): A meta-analysis of randomized controlled trials</article-title><source>PloS One</source><volume>9</volume><issue>2</issue><fpage>e88166</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0088166</pub-id><pub-id pub-id-type="pmid">24505411</pub-id></element-citation></ref><ref id="R4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haberer</surname><given-names>JE</given-names></name><name><surname>Musiimenta</surname><given-names>A</given-names></name><name><surname>Atukunda</surname><given-names>EC</given-names></name><name><surname>Musinguzi</surname><given-names>N</given-names></name><name><surname>Wyatt</surname><given-names>MA</given-names></name><name><surname>Ware</surname><given-names>NC</given-names></name><name><surname>Bangsberg</surname><given-names>DR</given-names></name></person-group><year>2016</year><article-title>Short message service (SMS) reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda</article-title><source>AIDS</source><volume>30</volume><issue>8</issue><fpage>1295</fpage><lpage>1299</lpage><pub-id pub-id-type="doi">10.1097/QAD.0000000000001021</pub-id><pub-id pub-id-type="pmid">26760452</pub-id></element-citation></ref><ref id="R5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haberer</surname><given-names>JE</given-names></name><name><surname>Musinguzi</surname><given-names>N</given-names></name><name><surname>Tsai</surname><given-names>AC</given-names></name><name><surname>Boum</surname><given-names>Y</given-names><suffix>2nd</suffix></name><name><surname>Bwana</surname><given-names>BM</given-names></name><name><surname>Muzoora</surname><given-names>C</given-names></name><name><surname>Bangsberg</surname><given-names>DR</given-names></name></person-group><year>2017</year><article-title>Real-time electronic adherence monitoring plus follow-up improves adherence compared with standard electronic adherence monitoring</article-title><source>AIDS</source><volume>31</volume><issue>1</issue><fpage>169</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1097/QAD.0000000000001310</pub-id><pub-id pub-id-type="pmid">27835622</pub-id></element-citation></ref><ref id="R6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>JD</given-names></name><name><surname>Giordano</surname><given-names>TP</given-names></name></person-group><year>2011</year><article-title>Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: A randomized controlled trial of text message reminders</article-title><source>AIDS</source><volume>25</volume><issue>8</issue><fpage>1137</fpage><comment>reply 1138&#x02013;1139</comment><pub-id pub-id-type="doi">10.1097/QAD.0b013e32834670d7</pub-id><pub-id pub-id-type="pmid">21537118</pub-id></element-citation></ref><ref id="R7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lester</surname><given-names>RT</given-names></name><name><surname>Ritvo</surname><given-names>P</given-names></name><name><surname>Mills</surname><given-names>EJ</given-names></name><name><surname>Kariri</surname><given-names>A</given-names></name><name><surname>Karanja</surname><given-names>S</given-names></name><name><surname>Chung</surname><given-names>MH</given-names></name><name><surname>Plummer</surname><given-names>FA</given-names></name></person-group><year>2010</year><article-title>Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): A randomised trial</article-title><source>The Lancet</source><volume>376</volume><issue>9755</issue><fpage>1838</fpage><lpage>1845</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(10)61997-6</pub-id></element-citation></ref><ref id="R8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Golin</surname><given-names>CE</given-names></name><name><surname>Miller</surname><given-names>LG</given-names></name><name><surname>Hays</surname><given-names>RD</given-names></name><name><surname>Beck</surname><given-names>CK</given-names></name><name><surname>Sanandaji</surname><given-names>S</given-names></name><name><surname>Wenger</surname><given-names>NS</given-names></name></person-group><year>2001</year><article-title>A comparison study of multiple measures of adherence to HIV protease inhibitors</article-title><source>Annals of Internal Medicine</source><volume>134</volume><issue>10</issue><fpage>968</fpage><lpage>977</lpage><pub-id pub-id-type="pmid">11352698</pub-id></element-citation></ref><ref id="R9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mannheimer</surname><given-names>SB</given-names></name><name><surname>Matts</surname><given-names>J</given-names></name><name><surname>Telzak</surname><given-names>E</given-names></name><name><surname>Chesney</surname><given-names>M</given-names></name><name><surname>Child</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>AW</given-names></name><name><surname>Friedland</surname><given-names>G</given-names></name></person-group><year>2005</year><article-title>Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence</article-title><source>AIDS Care</source><volume>17</volume><issue>1</issue><fpage>10</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">15832830</pub-id></element-citation></ref><ref id="R10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>S</given-names></name><name><surname>Elliott-DeSorbo</surname><given-names>DK</given-names></name><name><surname>Calabrese</surname><given-names>S</given-names></name><name><surname>Wolters</surname><given-names>PL</given-names></name><name><surname>Roby</surname><given-names>G</given-names></name><name><surname>Brennan</surname><given-names>T</given-names></name><name><surname>Wood</surname><given-names>LV</given-names></name></person-group><year>2009</year><article-title>A comparison of adherence assessment methods utilized in the United States: Perspectives of researchers, HIV-infected children, and their caregivers</article-title><source>AIDS Patient Care and STDs</source><volume>23</volume><issue>8</issue><fpage>593</fpage><lpage>601</lpage><pub-id pub-id-type="doi">10.1089/apc.2009.0021</pub-id><pub-id pub-id-type="pmid">19591601</pub-id></element-citation></ref><ref id="R11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mbuagbaw</surname><given-names>L</given-names></name><name><surname>van der Kop</surname><given-names>ML</given-names></name><name><surname>Lester</surname><given-names>RT</given-names></name><name><surname>Thirumurthy</surname><given-names>H</given-names></name><name><surname>Pop-Eleches</surname><given-names>C</given-names></name><name><surname>Ye</surname><given-names>C</given-names></name><name><surname>Thabane</surname><given-names>L</given-names></name></person-group><year>2013</year><article-title>Mobile phone text messages for improving adherence to antiretroviral therapy (ART): An individual patient data meta-analysis of randomised trials</article-title><source>BMJ Open</source><volume>3</volume><issue>12</issue><fpage>e003950</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2013-003950</pub-id></element-citation></ref><ref id="R12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mbuagbaw</surname><given-names>L</given-names></name><name><surname>Thabane</surname><given-names>L</given-names></name><name><surname>Ongolo-Zogo</surname><given-names>P</given-names></name><name><surname>Lester</surname><given-names>RT</given-names></name><name><surname>Mills</surname><given-names>EJ</given-names></name><name><surname>Smieja</surname><given-names>M</given-names></name><name><surname>Kouanfack</surname><given-names>C</given-names></name></person-group><year>2012</year><article-title>The Cameroon Mobile Phone SMS (CAMPS) trial: A randomized trial of text messaging versus usual care for adherence to antiretroviral therapy</article-title><source>PloS One</source><volume>7</volume><issue>12</issue><fpage>e46909</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0046909</pub-id><pub-id pub-id-type="pmid">23236345</pub-id></element-citation></ref><ref id="R13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>EJ</given-names></name><name><surname>Lester</surname><given-names>R</given-names></name><name><surname>Thorlund</surname><given-names>K</given-names></name><name><surname>Lorenzi</surname><given-names>M</given-names></name><name><surname>Muldoon</surname><given-names>K</given-names></name><name><surname>Kanters</surname><given-names>S</given-names></name><name><surname>Nachega</surname><given-names>JB</given-names></name></person-group><year>2014</year><article-title>Interventions to promote adherence to antiretroviral therapy in Africa: A network meta-analysis</article-title><source>The Lancet HIV</source><volume>1</volume><issue>3</issue><fpage>e104</fpage><lpage>e111</lpage><pub-id pub-id-type="doi">10.1016/S2352-3018(14)00003-4</pub-id><pub-id pub-id-type="pmid">26424119</pub-id></element-citation></ref><ref id="R14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orrell</surname><given-names>C</given-names></name><name><surname>Cohen</surname><given-names>K</given-names></name><name><surname>Mauff</surname><given-names>K</given-names></name><name><surname>Bangsberg</surname><given-names>DR</given-names></name><name><surname>Maartens</surname><given-names>G</given-names></name><name><surname>Wood</surname><given-names>R</given-names></name></person-group><year>2015</year><article-title>A randomized controlled trial of real-time electronic adherence monitoring with text message dosing reminders in people starting first-line antiretroviral therapy</article-title><source>JAIDS Journal of Acquired Immune Deficiency Syndromes</source><volume>70</volume><issue>5</issue><fpage>495</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1097/QAI.0000000000000770</pub-id><pub-id pub-id-type="pmid">26218411</pub-id></element-citation></ref><ref id="R15"><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Orrell</surname><given-names>CC</given-names></name><name><surname>Leisegang</surname><given-names>R</given-names></name><name><surname>Bangsberg</surname><given-names>DR</given-names></name><name><surname>Maartens</surname><given-names>G</given-names></name><name><surname>Wood</surname><given-names>R</given-names></name></person-group><year>2016</year><source>Comparing adherence methods: Which best predicts virological and resistance outcome?</source><conf-name>Paper presented at the CROI</conf-name><conf-loc>Boston</conf-loc></element-citation></ref><ref id="R16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palella</surname><given-names>FJ</given-names><suffix>Jr</suffix></name><name><surname>Delaney</surname><given-names>KM</given-names></name><name><surname>Moorman</surname><given-names>AC</given-names></name><name><surname>Loveless</surname><given-names>MO</given-names></name><name><surname>Fuhrer</surname><given-names>J</given-names></name><name><surname>Satten</surname><given-names>GA</given-names></name><name><surname>Holmberg</surname><given-names>SD</given-names></name></person-group><year>1998</year><article-title>Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators</article-title><source>The New England journal of Medicine</source><volume>338</volume><issue>13</issue><fpage>853</fpage><lpage>860</lpage><pub-id pub-id-type="doi">10.1056/NEJM199803263381301</pub-id><pub-id pub-id-type="pmid">9516219</pub-id></element-citation></ref><ref id="R17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pop-Eleches</surname><given-names>C</given-names></name><name><surname>Thirumurthy</surname><given-names>H</given-names></name><name><surname>Habyarimana</surname><given-names>JP</given-names></name><name><surname>Zivin</surname><given-names>JG</given-names></name><name><surname>Goldstein</surname><given-names>MP</given-names></name><name><surname>de Walque</surname><given-names>D</given-names></name><name><surname>Bangsberg</surname><given-names>DR</given-names></name></person-group><year>2011</year><article-title>Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: A randomized controlled trial of text message reminders</article-title><source>AIDS</source><volume>25</volume><issue>6</issue><fpage>825</fpage><lpage>834</lpage><pub-id pub-id-type="doi">10.1097/QAD.0b013e32834380c1</pub-id><pub-id pub-id-type="pmid">21252632</pub-id></element-citation></ref><ref id="R18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riaz</surname><given-names>T</given-names></name><name><surname>Riaz</surname><given-names>H</given-names></name><name><surname>Hussain</surname><given-names>SA</given-names></name><name><surname>Kherani</surname><given-names>D</given-names></name></person-group><year>2012</year><article-title>SMS reminders- future in self-care management of diabetes mellitus?</article-title><source>Diabetology &#x00026; Metabolic Syndrome</source><volume>4</volume><issue>1</issue><fpage>31</fpage><pub-id pub-id-type="doi">10.1186/1758-5996-4-31</pub-id><pub-id pub-id-type="pmid">22762775</pub-id></element-citation></ref><ref id="R19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabin</surname><given-names>LL</given-names></name><name><surname>Bachman DeSilva</surname><given-names>M</given-names></name><name><surname>Gill</surname><given-names>CJ</given-names></name><name><surname>Zhong</surname><given-names>L</given-names></name><name><surname>Vian</surname><given-names>T</given-names></name><name><surname>Xie</surname><given-names>W</given-names></name><name><surname>Gifford</surname><given-names>AL</given-names></name></person-group><year>2015</year><article-title>Improving adherence to antiretroviral therapy with triggered real-time text message reminders: The China adherence through technology study</article-title><source>JAIDS Journal of Acquired Immune Deficiency Syndromes</source><volume>69</volume><issue>5</issue><fpage>551</fpage><lpage>559</lpage><pub-id pub-id-type="doi">10.1097/QAI.0000000000000651</pub-id><pub-id pub-id-type="pmid">25886927</pub-id></element-citation></ref><ref id="R20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabin</surname><given-names>LL</given-names></name><name><surname>DeSilva</surname><given-names>MB</given-names></name><name><surname>Hamer</surname><given-names>DH</given-names></name><name><surname>Xu</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Gill</surname><given-names>CJ</given-names></name></person-group><year>2010</year><article-title>Using electronic drug monitor feedback to improve adherence to antiretroviral therapy among HIV-positive patients in China</article-title><source>AIDS and Behavior</source><volume>14</volume><issue>3</issue><fpage>580</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1007/s10461-009-9615-1</pub-id><pub-id pub-id-type="pmid">19771504</pub-id></element-citation></ref><ref id="R21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simoni</surname><given-names>JM</given-names></name><name><surname>Amico</surname><given-names>KR</given-names></name><name><surname>Smith</surname><given-names>L</given-names></name><name><surname>Nelson</surname><given-names>K</given-names></name></person-group><year>2010</year><article-title>Antiretroviral adherence interventions: Translating research findings to the real world clinic</article-title><source>Current HIV/AIDS Reports</source><volume>7</volume><issue>1</issue><fpage>44</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1007/s11904-009-0037-5</pub-id><pub-id pub-id-type="pmid">20425057</pub-id></element-citation></ref><ref id="R22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unge</surname><given-names>C</given-names></name><name><surname>Sodergard</surname><given-names>B</given-names></name><name><surname>Ekstrom</surname><given-names>AM</given-names></name><name><surname>Carter</surname><given-names>J</given-names></name><name><surname>Waweru</surname><given-names>M</given-names></name><name><surname>Ilako</surname><given-names>F</given-names></name><name><surname>Thorson</surname><given-names>A</given-names></name></person-group><year>2009</year><article-title>Challenges for scaling up ART in a resource-limited setting: A retrospective study in Kibera, Kenya</article-title><source>JAIDS Journal of Acquired Immune Deficiency Syndromes</source><volume>50</volume><issue>4</issue><fpage>397</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1097/QAI.0b013e318194618e</pub-id><pub-id pub-id-type="pmid">19214119</pub-id></element-citation></ref><ref id="R23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vodopivec-Jamsek</surname><given-names>V</given-names></name><name><surname>de Jongh</surname><given-names>T</given-names></name><name><surname>Gurol-Urganci</surname><given-names>I</given-names></name><name><surname>Atun</surname><given-names>R</given-names></name><name><surname>Car</surname><given-names>J</given-names></name></person-group><year>2012</year><article-title>Mobile phone messaging for preventive health care</article-title><source>Cochrane Database of Systematic Reviews</source><volume>12</volume><fpage>CD007457</fpage><pub-id pub-id-type="doi">10.1002/14651858.CD007457.pub2</pub-id><pub-id pub-id-type="pmid">23235643</pub-id></element-citation></ref><ref id="R24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>IB</given-names></name><name><surname>Bangsberg</surname><given-names>DR</given-names></name><name><surname>Shen</surname><given-names>J</given-names></name><name><surname>Simoni</surname><given-names>JM</given-names></name><name><surname>Reynolds</surname><given-names>NR</given-names></name><name><surname>Goggin</surname><given-names>K</given-names></name><collab>Multisite Adherence Collaboration on, H. I. V. I</collab></person-group><year>2013</year><article-title>Heterogeneity among studies in rates of decline of antiretroviral therapy adherence over time: Results from the multisite adherence collaboration on HIV 14 study</article-title><source>JAIDS Journal of Acquired Immune Deficiency Syndromes</source><volume>64</volume><issue>5</issue><fpage>448</fpage><lpage>454</lpage><pub-id pub-id-type="doi">10.1097/QAI.0000000000000025</pub-id><pub-id pub-id-type="pmid">24225904</pub-id></element-citation></ref><ref id="R25"><element-citation publication-type="web"><collab>Wisepill Technologies</collab><year>2016</year><comment>Retrieved from <ext-link ext-link-type="uri" xlink:href="http://www.wisepill.com">http://www.wisepill.com</ext-link></comment></element-citation></ref></ref-list></back><floats-group><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Analytic sample: baseline characteristics by randomization group.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="middle" align="left" rowspan="1" colspan="1">No. (%)</th><th valign="middle" align="center" rowspan="1" colspan="1">No intervention (n = 54)</th><th valign="middle" align="center" rowspan="1" colspan="1">Intervention: text message (n = 54)</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Characteristic</bold></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sex</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Male</td><td valign="top" align="center" rowspan="1" colspan="1">29 (53.7)</td><td valign="top" align="center" rowspan="1" colspan="1">31 (57.4)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Female</td><td valign="top" align="center" rowspan="1" colspan="1">25 (46.3)</td><td valign="top" align="center" rowspan="1" colspan="1">23 (42.6)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Age</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;17&#x02013;34</td><td valign="top" align="center" rowspan="1" colspan="1">9 (16.7)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (14.8)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;35&#x02013;49</td><td valign="top" align="center" rowspan="1" colspan="1">39 (72.2)</td><td valign="top" align="center" rowspan="1" colspan="1">38 (70.4)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;50&#x02013;67</td><td valign="top" align="center" rowspan="1" colspan="1">6 (11.1)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (14.8)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Years of post-primary education</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;None</td><td valign="top" align="center" rowspan="1" colspan="1">25 (46.3)</td><td valign="top" align="center" rowspan="1" colspan="1">29 (53.7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;1&#x02013;2</td><td valign="top" align="center" rowspan="1" colspan="1">6 (11.1)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (13.0)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;3 or more</td><td valign="top" align="center" rowspan="1" colspan="1">23 (42.6)</td><td valign="top" align="center" rowspan="1" colspan="1">18 (33.3)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Travel time to clinic</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Less than one hour</td><td valign="top" align="center" rowspan="1" colspan="1">39 (72.2)</td><td valign="top" align="center" rowspan="1" colspan="1">32 (59.3)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;One hour or more</td><td valign="top" align="center" rowspan="1" colspan="1">15 (27.8)</td><td valign="top" align="center" rowspan="1" colspan="1">22 (40.7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Pay any portion of medication costs?</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;No</td><td valign="top" align="center" rowspan="1" colspan="1">6 (11.1)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (5.7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td valign="top" align="center" rowspan="1" colspan="1">48 (88.9)</td><td valign="top" align="center" rowspan="1" colspan="1">51 (94.4)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Does cost prevent regular treatment?</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;No</td><td valign="top" align="center" rowspan="1" colspan="1">52 (96.3)</td><td valign="top" align="center" rowspan="1" colspan="1">52 (96.3)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td valign="top" align="center" rowspan="1" colspan="1">2 (3.7)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (3.7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Time of ART initiation:</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Four years ago or less</td><td valign="top" align="center" rowspan="1" colspan="1">14 (25.9)</td><td valign="top" align="center" rowspan="1" colspan="1">15 (27.8)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;More than four years</td><td valign="top" align="center" rowspan="1" colspan="1">40 (74.1)</td><td valign="top" align="center" rowspan="1" colspan="1">39 (72.3)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Experience discomfort or side effects from medications?</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;No</td><td valign="top" align="center" rowspan="1" colspan="1">41 (75.9)</td><td valign="top" align="center" rowspan="1" colspan="1">42 (77.8)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td valign="top" align="center" rowspan="1" colspan="1">13 (24.1)</td><td valign="top" align="center" rowspan="1" colspan="1">12 (22.2)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Do side effects make it difficult to take regular treatment?</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;No</td><td valign="top" align="center" rowspan="1" colspan="1">53 (98.2)</td><td valign="top" align="center" rowspan="1" colspan="1">54 (100.0)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td valign="top" align="center" rowspan="1" colspan="1">1 (1.9)</td><td valign="top" align="center" rowspan="1" colspan="1">0 (0.0)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Disclosure of HIV status:</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;No</td><td valign="top" align="center" rowspan="1" colspan="1">6 (11.1)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (14.8)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td valign="top" align="center" rowspan="1" colspan="1">48 (88.9)</td><td valign="top" align="center" rowspan="1" colspan="1">46 (85.2)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Is your illness a secret from others in your family?</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;No</td><td valign="top" align="center" rowspan="1" colspan="1">19 (35.2)</td><td valign="top" align="center" rowspan="1" colspan="1">21 (38.9)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td valign="top" align="center" rowspan="1" colspan="1">35 (64.8)</td><td valign="top" align="center" rowspan="1" colspan="1">33 (61.1)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Is your illness a secret from others in your community?</td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;No</td><td valign="top" align="center" rowspan="1" colspan="1">5 (9.3)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (9.3)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td valign="top" align="center" rowspan="1" colspan="1">49 (90.7)</td><td valign="top" align="center" rowspan="1" colspan="1">49 (90.7)</td></tr></tbody></table></table-wrap><table-wrap id="T2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Analytic sample: outcome measures.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">No. (%)</th><th valign="top" align="center" rowspan="1" colspan="1">No intervention (n = 54)</th><th valign="top" align="center" rowspan="1" colspan="1">Intervention: text message (n = 54)</th><th valign="top" align="center" rowspan="1" colspan="1">P value</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Adherence</bold></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">0 (no visits)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (5.6)</td><td valign="top" align="center" rowspan="1" colspan="1">0 (0.0)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">17% (1 visit)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (7.4)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (5.6)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">33% (2 visits)</td><td valign="top" align="center" rowspan="1" colspan="1">0 (0.0)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (1.9)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">50% (3 visits)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (1.9)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (1.9)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">67% (4 visits)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (7.4)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (3.7)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">83% (5 visits)</td><td valign="top" align="center" rowspan="1" colspan="1">4 (7.4)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (1.9)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">100% (6 or more visits)</td><td valign="top" align="center" rowspan="1" colspan="1">38 (70.4)</td><td valign="top" align="center" rowspan="1" colspan="1">46 (85.2)</td><td valign="top" align="center" rowspan="1" colspan="1">0.27</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Doctor visits</bold></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">None</td><td valign="top" align="center" rowspan="1" colspan="1">44 (81.5)</td><td valign="top" align="center" rowspan="1" colspan="1">45 (83.3)</td><td valign="top" align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">One</td><td valign="top" align="center" rowspan="1" colspan="1">7 (13.0)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (13.0)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Two</td><td valign="top" align="center" rowspan="1" colspan="1">3 (5.6)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (3.7)</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Laboratory results</bold></td><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mean CD4, enrollment (SD)</td><td valign="top" align="center" rowspan="1" colspan="1">378.1 (290.6)<xref rid="TFN1" ref-type="table-fn">*</xref></td><td valign="top" align="center" rowspan="1" colspan="1">405.9 (243.3)<xref rid="TFN2" ref-type="table-fn">&#x000a7;</xref></td><td valign="top" align="center" rowspan="1" colspan="1">0.62</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mean CD4, at last visit in past six months (SD)</td><td valign="top" align="center" rowspan="1" colspan="1">389.5 (281.2)<xref rid="TFN1" ref-type="table-fn">*</xref></td><td valign="top" align="center" rowspan="1" colspan="1">432.1 (269.0)<xref rid="TFN2" ref-type="table-fn">&#x000a7;</xref></td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mean Change in CD4 (SD)</td><td valign="top" align="center" rowspan="1" colspan="1">9.2 (93.6)<xref rid="TFN1" ref-type="table-fn">*</xref></td><td valign="top" align="center" rowspan="1" colspan="1">20.9 (88.7)<xref rid="TFN2" ref-type="table-fn">&#x000a7;</xref></td><td valign="top" align="center" rowspan="1" colspan="1">0.53</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Log of VL, at enrollment (SD)</td><td valign="top" align="center" rowspan="1" colspan="1">5.59 (3.76)<xref rid="TFN3" ref-type="table-fn">&#x02020;</xref></td><td valign="top" align="center" rowspan="1" colspan="1">3.90 (1.89)<xref rid="TFN4" ref-type="table-fn">&#x02020;&#x02020;</xref></td><td valign="top" align="center" rowspan="1" colspan="1">0.005</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Log of VL, at last visit in past six months (SD)</td><td valign="top" align="center" rowspan="1" colspan="1">5.31 (3.60)<xref rid="TFN3" ref-type="table-fn">&#x02020;</xref></td><td valign="top" align="center" rowspan="1" colspan="1">3.88 (2.03)<xref rid="TFN4" ref-type="table-fn">&#x02020;&#x02020;</xref></td><td valign="top" align="center" rowspan="1" colspan="1">0.005</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Change in Log VL</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.24 (1.39)<xref rid="TFN3" ref-type="table-fn">&#x02020;</xref></td><td valign="top" align="center" rowspan="1" colspan="1">0.09 (0.53)<xref rid="TFN4" ref-type="table-fn">&#x02020;&#x02020;</xref></td><td valign="top" align="center" rowspan="1" colspan="1">0.14</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>*</label><p>N = 48.</p></fn><fn id="TFN2"><label>&#x000a7;</label><p>N = 47.</p></fn><fn id="TFN3"><label>&#x02020;</label><p>N = 45.</p></fn><fn id="TFN4"><label>&#x02020;&#x02020;</label><p>N = 46.</p></fn></table-wrap-foot></table-wrap></floats-group></article>